Head-to-head · WeighScore
EmbraceRX vs Modern Age
The verdict
Modern Age takes it — 58.7/100 to 58.6/100, but only just.
Modern Age grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Modern Age is a longevity-focused health clinic that uses FDA-approved branded GLP-1 medication (semaglutide - Wegovy/Ozempic) within a structured Weight Loss Program. EmbraceRX is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | EmbraceRX | Modern Age |
|---|---|---|
| WeighScore | 58.6/100 | 58.7/100 |
| Grade | C | C |
| Scorecard rank | #363 | #362 |
| Semaglutide | Not disclosed | Not disclosed |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Yes | Injection only |
Graded #363 · C
Strengths
- Broad compounded GLP-1 menu — semaglutide (+B12), tirzepatide, oral semaglutide/tirzepatide capsules, plus Lipo-B
- Large peptide/longevity catalog (BPC-157, GHK-Cu, NAD+, MOTS-C) across injectable, oral, topical, and nasal formats
- Clinician-guided, compounded at FDA-registered pharmacies; partners with a licensed physician network (Samaritan MD)
- Full legal suite published (Terms, Privacy, HIPAA Notice, CCPA, Returns & Refunds)
Where it loses points
- Pricing not shown upfront — revealed only at checkout after a dose selection
- Offers investigational/research compounds (e.g., retatrutide, AOD-9604) that are not FDA-approved
- Compounding pharmacy partner not named ('FDA-registered pharmacies')
- Not LegitScript-certified (no certification displayed)
Graded #362 · C
Strengths
- Uses FDA-approved branded GLP-1 medication (Wegovy/Ozempic), no compounding
- Comprehensive assessment with labs, at-home tests and clinician review
- Board-certified clinicians and structured 6-month program
- Longevity-oriented, whole-person approach beyond weight loss
Where it loses points
- Expensive: $500 assessment plus $500 program, with medication billed separately
- Branded GLP-1 can cost $900-1600/mo if not covered by insurance
- Only available in 16 states (specific states not listed publicly)
- Premium positioning makes it costlier than compounded-subscription rivals
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.